Natural history and management of hepatitis C infection after liver transplantation

被引:27
作者
Charlton, M
Wiesner, R
机构
[1] Mayo Clin & Mayo Fdn, Transplant Ctr CH 10, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
HCV natural history; HCV management;
D O I
10.1055/s-2004-832932
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
With almost universal virological recurrence and a projected several-fold increase in HCV-related end-stage liver disease within the next decade, a clear understanding of the natural history of posttransplant HCV infection and optimization of the management of recurrent HCV infection are imperative. This article describes the natural history, risk factors, and current strategies for the amelioration of posttransplant HCV infection.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 73 条
  • [51] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    McHutchison, JG
    Gordon, SC
    Schiff, ER
    Shiffman, ML
    Lee, WM
    Rustgi, VK
    Goodman, ZD
    Ling, MH
    Cort, S
    Albrecht, JK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1485 - 1492
  • [52] Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy
    Menon, KVN
    Poterucha, JJ
    El-Amin, OM
    Burgart, LJ
    Kremers, WK
    Rosen, CB
    Wiesner, RH
    Charlton, M
    [J]. LIVER TRANSPLANTATION, 2002, 8 (07) : 623 - 629
  • [53] Min AD, 1998, AM J GASTROENTEROL, V93, P2148, DOI 10.1111/j.1572-0241.1998.00611.x
  • [54] Nery J, 1994, Transpl Int, V7 Suppl 1, pS229
  • [55] The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis
    Papatheodoridis, GV
    Davies, S
    Dhillon, AP
    Teixeira, R
    Goulis, J
    Davidson, B
    Rolles, K
    Dusheiko, G
    Burroughs, AK
    [J]. TRANSPLANTATION, 2001, 72 (03) : 412 - 418
  • [56] Pirenne J, 2001, HEPATOLOGY, V34, p408A
  • [57] Prieto M, 2000, HEPATOLOGY, V32, p261A
  • [58] Immunological and virological effects of ribavirin in hepatitis C after liver transplantation
    Quadri, R
    Giostra, E
    Roskams, T
    Pawlotsky, JM
    Mentha, G
    Rubbia-Brandt, L
    Perrin, L
    Hadengue, A
    Negro, F
    [J]. TRANSPLANTATION, 2002, 73 (03) : 373 - 378
  • [59] Cytomegalovirus viremia - Risk factor for allograft cirrhosis after liver transplantation for hepatitis C
    Rosen, HR
    Chou, SW
    Corless, CL
    Gretch, DR
    Flora, KD
    Boudousquie, A
    Orloff, SL
    Rabkin, JM
    Benner, KG
    [J]. TRANSPLANTATION, 1997, 64 (05) : 721 - 726
  • [60] Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation
    Sánchez-Fueyo, A
    Giménez-Barcons, M
    Puig-Basagoiti, F
    Rimola, A
    Sánchez-Tapias, JM
    Sáiz, JC
    Rodés, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) : 266 - 275